Palm Therapeutics has developed a novel, rapid screening system to find protein-specific inhibitors of palmitoylation. First target is pan-NRAS-mutant cancers.
Location: United States, California, San Diego
Employees: 1-10
Investors 3
| Date | Name | Website |
| 01.12.2024 | SeedFolio | seedfolio.... |
| 08.07.2022 | Creative D... | creativede... |
| 01.02.2024 | Tachyon Ve... | tachyon.vc |